Related Experiment Video

Updated: May 15, 2026

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Controversies in neurology, Vienna, 2012: steroids in bacterial meningitis: no

Bettina Pfausler1, Erich Schmutzhard

  • 1Department of Neurology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

Journal of Neural Transmission (Vienna, Austria : 1996)
|December 25, 2012
PubMed

Insights

Dexamethasone use in acute bacterial meningitis is often futile, especially in low-income countries. Evidence does not support its routine use, as it may increase risks and offers limited benefit, particularly when not given before antibiotics.

Area of Science:

  • Infectious Diseases
  • Neurology
  • Critical Care Medicine

Background:

  • Acute bacterial meningitis remains a significant cause of morbidity and mortality, particularly in low and middle-income countries.
  • Meningococci are a frequent cause of bacterial meningitis globally.
  • The role of dexamethasone in bacterial meningitis is controversial, with limited evidence of benefit in many populations.

Purpose of the Study:

  • To evaluate the efficacy and safety of dexamethasone in the management of acute bacterial meningitis.
  • To assess the impact of dexamethasone on glucose and coagulation homeostasis in meningitis patients.
  • To determine if dexamethasone improves long-term outcomes in bacterial meningitis.

Main Methods:

  • Review of over 20 prospective trials on dexamethasone use in bacterial meningitis.
  • Analysis of patient populations, including geographical location and age, in relation to dexamethasone efficacy.
  • Examination of the effects of dexamethasone on glucose variability and coagulation.

Main Results:

  • Dexamethasone has shown limited benefit in improving outcomes for the majority of bacterial meningitis patients.
  • A potential positive effect of dexamethasone is observed only when administered before the first antibiotic dose.
  • Concerns exist regarding dexamethasone's potential to worsen glucose and coagulation derangements, which are detrimental in meningitis.

Conclusions:

  • The routine use of dexamethasone in acute bacterial meningitis is not supported by current evidence.
  • The timing of dexamethasone administration (before antibiotics) is critical for any potential benefit.
  • The introduction of pre-hospital antibiotics makes the discussion of dexamethasone in acute bacterial meningitis largely irrelevant.

More Related Videos

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...